Paracrine, INC.
Paracrine harnesses the body's innate power to heal, focusing on first-line treatments for non-healing wounds. The company emphasizes its scientific approach and clinical pipeline to develop innovative healing solutions.
Industries
biotechnology
Nr. of Employees
small (1-50)
Paracrine, INC.
San Diego, California, United States, North America
Patents
Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
US-11633382-B2
View Details
Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
US-11633382-B2
View DetailsProducts
Clinical-stage therapeutic candidate for non-healing wounds
A clinical-stage therapeutic intended as a first-line treatment for chronic or non-healing wounds.
Clinical-stage therapeutic candidate for non-healing wounds
A clinical-stage therapeutic intended as a first-line treatment for chronic or non-healing wounds.
Expertise Areas
- Clinical trial management
- Regenerative medicine
- Wound care therapeutics
- Translational research
Key Technologies
- Regenerative medicine approaches
- Paracrine/secretome-based biologics
- Wound-healing therapeutics
- Translational preclinical models